Ignite Creation Date:
2025-12-24 @ 11:55 PM
Ignite Modification Date:
2026-01-24 @ 8:51 PM
Study NCT ID:
NCT00187551
Status:
COMPLETED
Last Update Posted:
2011-02-10
First Post:
2005-09-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance
Sponsor:
University of California, San Francisco
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | HIV Infections | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | enfuvirtide | View |
| None | T20 | View |
| None | Fuzeon | View |
| None | Treatment | View |
| None | Interruption | View |
| None | Resistance | View |
| None | HIV Drug Resistance | View |
| None | Antiretroviral Agents | View |
| None | Salvage Therapy | View |
| None | Drug Resistance, Multiple | View |
| None | Human Immunodeficiency virus | View |